The tissue engineering sub-industry involves creating biological substitutes to restore tissue function. In 2024, innovations in regenerative medicine and 3D bioprinting are driving growth.
Cautious investment is suggested. There may be selective opportunities for turnaround specialists or those with high risk tolerance.